Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.
Anya K BershadHarriet de WitPublished in: Schizophrenia bulletin (2023)
Given the acute effects of these drugs on behavioral and performance-based measures of social motivation in healthy volunteers, they may be particularly beneficial as an adjunct to psychosocial training programs in patient populations. It remains to be determined how these medications affect patients with deficits in social motivation, and in which contexts they may be most effectively administered.